UNASSIGNED: In July 2020, a 73-year-old male patient presented at our institution with mild abdominal pain and an attack of intense cold. After a radiological workup, the diagnosis of HCC located in the caudate lobe was established. The patient underwent atypical caudate lobe resection, and pathology confirmed the diagnosis of grade 3 HCC. Postoperative MRI showed a new metastasis in the 6th liver segment 1.3 cm in diameter, and a PVT progression which now affected the whole right lobe. The patient was started on sorafenib and demonstrated a complete response which still lasts for more than two years.
UNASSIGNED: We present a rare case of a patient who demonstrated a complete response to sorafenib treatment in advanced HCC with unfavorable prognostic factors.
2020年7月,一名73岁的男性患者在我们机构就诊,患有轻度腹痛和强烈感冒。经过放射检查,确定了位于尾状叶的HCC的诊断。患者接受了非典型尾状叶切除术,病理证实诊断为3级肝癌。术后MRI显示直径1.3cm的第6段肝新转移,和PVT进展,现在影响了整个右叶。患者开始服用索拉非尼,并表现出完全反应,仍持续两年以上。
■我们介绍了一例罕见的患者,该患者对索拉非尼治疗在晚期HCC中表现出完全反应,并具有不良预后因素。